BLTE
Price
$148.73
Change
-$1.10 (-0.73%)
Updated
Jun 26 closing price
Capitalization
5.96B
46 days until earnings call
Intraday BUY SELL Signals
DNTH
Price
$95.35
Change
+$3.78 (+4.13%)
Updated
Jun 26 closing price
Capitalization
5.21B
40 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BLTE vs DNTH

BLTE vs DNTH Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BLTE vs. DNTH commentary
Jun 28, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLTE is a Hold and DNTH is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2026
Stock price -- (BLTE: $148.73 vs. DNTH: $95.35)
Brand notoriety: BLTE and DNTH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BLTE: 133% vs. DNTH: 613%
Market capitalization -- BLTE: $5.96B vs. DNTH: $5.21B
BLTE [@Biotechnology] is valued at $5.96B. DNTH’s [@Biotechnology] market capitalization is $5.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $124.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLTE’s FA Score shows that 0 FA rating(s) are green whileDNTH’s FA Score has 1 green FA rating(s).

  • BLTE’s FA Score: 0 green, 5 red.
  • DNTH’s FA Score: 1 green, 4 red.
According to our system of comparison, DNTH is a better buy in the long-term than BLTE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLTE’s TA Score shows that 4 TA indicator(s) are bullish while DNTH’s TA Score has 4 bullish TA indicator(s).

  • BLTE’s TA Score: 4 bullish, 4 bearish.
  • DNTH’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BLTE is a better buy in the short-term than DNTH.

Price Growth

BLTE (@Biotechnology) experienced а +1.79% price change this week, while DNTH (@Biotechnology) price change was +15.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.08%. For the same industry, the average monthly price growth was +1.67%, and the average quarterly price growth was +1916.03%.

Reported Earning Dates

BLTE is expected to report earnings on Aug 12, 2026.

DNTH is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (+4.08% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLTE($5.96B) has a higher market cap than DNTH($5.21B). DNTH YTD gains are higher at: 131.206 vs. BLTE (-6.733). BLTE has higher annual earnings (EBITDA): -94.78M vs. DNTH (-190.92M). DNTH has more cash in the bank: 1.11B vs. BLTE (276M). BLTE has less debt than DNTH: BLTE (510K) vs DNTH (1.36M). DNTH has higher revenues than BLTE: DNTH (1.34M) vs BLTE (0).
BLTEDNTHBLTE / DNTH
Capitalization5.96B5.21B114%
EBITDA-94.78M-190.92M50%
Gain YTD-6.733131.206-5%
P/E RatioN/A3.24-
Revenue01.34M-
Total Cash276M1.11B25%
Total Debt510K1.36M37%
FUNDAMENTALS RATINGS
DNTH: Fundamental Ratings
DNTH
OUTLOOK RATING
1..100
38
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
5
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
62
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BLTEDNTH
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 13 days ago
79%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 23 days ago
86%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BLTE
Daily Signal:
Gain/Loss:
DNTH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FITE105.462.08
+2.02%
Stt Strt® SPDR® S&PKenshoFutSecETF
WCEO38.210.52
+1.38%
Hypatia Women CEO ETF
IWP141.620.49
+0.35%
iShares Russell Mid-Cap Growth ETF
YYY11.530.02
+0.17%
Amplify CEF High Income ETF
TAXM50.440.04
+0.07%
Bondbloxx Ir+M Tax-Aware ETF For Massachusetts Residents

BLTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLTE has been loosely correlated with RAIN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BLTE jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLTE
1D Price
Change %
BLTE100%
-0.43%
RAIN - BLTE
48%
Loosely correlated
-3.50%
DNTH - BLTE
28%
Poorly correlated
+4.05%
PRAX - BLTE
28%
Poorly correlated
-0.02%
RYTM - BLTE
25%
Poorly correlated
+1.50%
XNCR - BLTE
25%
Poorly correlated
+2.37%
More

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with XENE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
+4.05%
XENE - DNTH
42%
Loosely correlated
+5.20%
EDIT - DNTH
42%
Loosely correlated
+4.38%
REPL - DNTH
41%
Loosely correlated
+4.49%
ROIV - DNTH
39%
Loosely correlated
+0.15%
VYGR - DNTH
39%
Loosely correlated
+0.56%
More